Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 3Phase 1 3Phase 2/3 1Phase 1/2 1

Status

Completed 3

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 8Gastrointestinal Neoplasms 4Esophageal Neoplasms 3Biliary Tract Neoplasms 3Advanced Solid Tumors 3Neoplasms 2Colorectal Neoplasms 2Patients With Advanced or Metastatic Solid Tumors 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Gastric Adenocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 13Cisplatin 9Capecitabine 7durvalumab 6pembrolizumab 4tremelimumab 3S 1 (combination) 3Nivolumab 3AZD 6244 3Ramucirumab 2Fluorouracil 2130-nm albumin-bound paclitaxel 2vandetanib 1trifluridine tipiracil drug combination 1trametinib 1tocilizumab 1titanium silicide 1sacituzumab govitecan 1poly ICLC 1futibatinib 1fludarabine 1cemiplimab 1binimetinib 1aflibercept 1Tegafur 1TAS-116 1Psilocybin 1Peptides 1Oxaliplatin 1NUC-1031 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Biliary Tract Neoplasms × S 1 (combination) × Clear all
NCT03162510 2022-04-07

SOLAR

National Health Research Institutes, Taiwan

Phase 1 Completed
18 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT01713387 2017-10-09

A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy

Kansai Hepatobiliary Oncology Group

Phase 1 Completed
38 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT01291615 2014-10-23

Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Kansai Hepatobiliary Oncology Group

Phase 1 Completed
6 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡